First Trust Capital Management L.P. 2seventy Bio, Inc. Transaction History
First Trust Capital Management L.P.
- $750 Million
- Q1 2025
A detailed history of First Trust Capital Management L.P. transactions in 2seventy Bio, Inc. stock. As of the latest transaction made, First Trust Capital Management L.P. holds 1,143,962 shares of TSVT stock, worth $5.72 Million. This represents 0.75% of its overall portfolio holdings.
Number of Shares
1,143,962Holding current value
$5.72 Million% of portfolio
0.75%Shares
1 transactions
Others Institutions Holding TSVT
# of Institutions
153Shares Held
46.7MCall Options Held
116KPut Options Held
7.5K-
Goldman Sachs Group Inc New York, NY4.68MShares$23.4 Million0.0% of portfolio
-
Beryl Capital Management LLC Redondo Beach, CA4.25MShares$21.3 Million8.75% of portfolio
-
Black Rock Inc. New York, NY3.66MShares$18.3 Million0.0% of portfolio
-
Morgan Stanley New York, NY2.97MShares$14.8 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.82MShares$14.1 Million0.0% of portfolio
About 2seventy bio, Inc.
- Ticker TSVT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 37,873,600
- Market Cap $189M
- Description
- 2seventy bio, Inc., a cell and gene therapy company, focuses on the research, development, and commercialization of treatments for cancer in the United States. Its products pipeline includes idecabtagene vicleucel; ide-cel or Abecma and bb21217; and CAR-T cell product candidates for the treatment of multiple myeloma. 2seventy bio, Inc. has a col...